These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2366189)

  • 1. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine.
    Martin TJ; Suchocki J; May EL; Martin BR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):45-51. PubMed ID: 2366189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of calcium and L-type channels in nicotine-induced antinociception.
    Damaj MI; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1330-8. PubMed ID: 7690401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
    Damaj MI; Slemmer JE; Carroll FI; Martin BR
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine.
    Haikala H; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):169-73. PubMed ID: 3185744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for nicotinic antagonists in the CNS.
    Martin TJ; Suchocki J; May EL; Martin BR
    NIDA Res Monogr; 1989; 95():514-5. PubMed ID: 2641046
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.
    Damaj MI; Glassco W; Marks MJ; Slobe B; James JR; May EL; Rosecrans JA; Collins AC; Martin BR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1425-34. PubMed ID: 9316856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
    Damaj MI; Glassco W; Aceto MD; Martin BR
    J Pharmacol Exp Ther; 1999 Oct; 291(1):390-8. PubMed ID: 10490929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions.
    Martin BR; Tripathi HL; Aceto MD; May EL
    J Pharmacol Exp Ther; 1983 Jul; 226(1):157-63. PubMed ID: 6864536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
    Tripathi HL; Martin BR; Aceto MD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):91-6. PubMed ID: 7062295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
    Chadman KK; Woods JH
    J Pharmacol Exp Ther; 2004 Jan; 308(1):73-8. PubMed ID: 14566012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure.
    Kunin D; Bloch RT; Smith BR; Amit Z
    Psychopharmacology (Berl); 2001 Dec; 159(1):70-6. PubMed ID: 11797072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nicotinic properties of anticholinergic antiparkinson drugs.
    Gao ZG; Liu BY; Cui WY; Li LJ; Fan QH; Liu CG
    J Pharm Pharmacol; 1998 Nov; 50(11):1299-305. PubMed ID: 9877318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of mecamylamine and pempidine, secondary and tertiary amines, on the spinal reflex of cats (author's transl)].
    Yamada S; Hachisu M; Ohata H; Kamimura T; Maruyama I
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):469-76. PubMed ID: 7297958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of nicotine-induced seizures in mice.
    Damaj MI; Glassco W; Dukat M; Martin BR
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1284-91. PubMed ID: 10565853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization and tolerance with episodic (weekly) nicotine on motor activity in rats.
    MacPhail RC; Farmer JD; Jarema KA
    Neurotoxicol Teratol; 2007; 29(3):341-7. PubMed ID: 17261359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
    Damaj MI; Fei-Yin M; Dukat M; Glassco W; Glennon RA; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
    Teng L; Crooks PA; Buxton ST; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion is a nicotinic antagonist.
    Slemmer JE; Martin BR; Damaj MI
    J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.